JSMU VC reappointment sparks debate as YDA Sindh questions legality

*Click the Title above to view complete article on https://www.medicalnews.pk/.

A rare second term extension at Jinnah Sindh Medical University triggers sharp reaction from doctors—raising bigger questions about merit, policy consistency, and governance in Sindh’s medical education system

2026-03-26T13:08:00+05:00 Staff Reporter

KARACHI: In a development that is rapidly gaining attention, Jinnah Sindh Medical University (JSMU) Vice Chancellor Dr. Amjad Siraj Memon has been granted a second four-year term—an unusual move that is now sparking serious debate across the healthcare and academic landscape.

According to the official notification dated December 30, 2025, Dr. Amjad Siraj Memon has been reappointed as Vice Chancellor for another four-year term, even though his first tenure was set to conclude on January 24, 2026.

Following this, Registrar Azam Khan issued a formal communication confirming that Dr. Memon has assumed charge for his second term.

The justification?

“Exemplary performance”

But the timing—and the decision itself—has raised eyebrows.

For nearly two and a half years, the Government of Sindh had reportedly maintained a consistent stance:

No second terms for vice chancellors
No exceptions—despite political and administrative pressure

Yet, in this case, that policy appears to have shifted.

And that shift is exactly where the controversy begins.

The reaction from Young Doctors Association Sindh (YDA Sindh) was swift—and pointed.

In a strongly worded response, YDA Sindh questioned the legality of the move, urging Chief Minister Sindh to reconsider the decision.

Their core argument:

Reappointing the same Vice Chancellor for a second term goes against established norms
It risks undermining transparency and merit-based selection

The association warned that such decisions could set a precedent that weakens institutional integrity.

Performance vs policy: the central question

Supporters of the move argue that continuity in leadership—especially when performance is strong—can benefit institutional growth.

Critics, however, see a deeper issue:

Should performance override policy consistency?
Or should systems remain stronger than individuals?

This tension between merit and governance is now at the heart of the debate.

As this story continues to unfold, the medical community—and the public—will be watching closely.

Stay informed, stay ahead
CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for real-time updates on healthcare, policy, and medical education.

View More News